HomeJANX • NASDAQ
add
Janux Therapeutics Inc
Previous close
$47.10
Day range
$46.51 - $48.23
Year range
$5.65 - $58.69
Market cap
2.45B USD
Avg Volume
727.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 2.46M | -13.50% |
Operating expense | 53.41M | 2.94% |
Net income | -11.76M | 26.81% |
Net profit margin | -477.77 | 15.39% |
Earnings per share | -0.25 | 35.90% |
EBITDA | -15.61M | 12.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 344.03M | 5.20% |
Total assets | 380.41M | 4.50% |
Total liabilities | 36.06M | -16.67% |
Total equity | 344.35M | — |
Shares outstanding | 51.65M | — |
Price to book | 6.32 | — |
Return on assets | -10.52% | — |
Return on capital | -10.86% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -11.76M | 26.81% |
Cash from operations | -9.90M | 16.89% |
Cash from investing | 11.12M | 793.45% |
Cash from financing | 831.00K | 335.08% |
Net change in cash | 2.05M | 115.41% |
Free cash flow | -6.81M | 26.84% |
About
Founded
2017
Website
Employees
64